Mobile market enters off-season as panel prices hold steady
Following the Lunar New Year holidays, the mobile panel market has officially entered its traditional off-season. While China’s subsidy policies…
Embolization Device Recall and Correction: Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device with Shield Technology, Updates Use Instructions for 021 Compatible Pipeline Vantage Embolization Devices due to Increased Risk of Inco
Pipeline Vantage Embolization Devices block off blood flow to intracranial aneurysms. Some devices do not attach properly or fail to…
Edge AI to present bigger opportunities, says YS Tech
The development of edge AI, driven by DeepSeek, has garnered attention and created opportunities for new suppliers aiming to position…
Intel fires up 18A test production in Arizona, betting big on foundry revival
Intel has begun test production of its 18A process at its Arizona facility, a key step in its bid to…
TSMC and Avnet take center stage in Arizona governor’s second Taiwan visit
Taiwan Semiconductor Manufacturing Co. (TSMC) has confirmed a high-stakes meeting with Arizona Gov. Katie Hobbs at its Hsinchu headquarters took…
With Samsung at make-or-break moment, chairman Lee Jae-yong issues blunt warning to top executives
Samsung Electronics Chairman Lee Jae-yong has reportedly issued a blunt warning to top executives, acknowledging that the company is at…
GTC 2025: WinWay to present new test socket solutions for AI
The five-day Nvidia GPU Technology Conference (GTC) officially kicked off on March 17 US time, focusing on innovative applications such…
UPS slaps temporary fee on China-to-US shipments
The $0.29 per pound surcharge is active until March 29, adding to other expenses parcel shippers are navigating.
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Industry Resources
Information to assist the drug manufacturing industry in the development of generic drugs and the completion of abbreviated new drug…